Plain-English translation of NCT07347054 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether injections of triamcinolone acetonide (a steroid medication) into painful trigger points in shoulder muscles work as well as injections directly into the shoulder joint for treating shoulder osteoarthritis. You would receive one type of injection and be followed for two years to measure your pain relief and any side effects. The goal is to find out if trigger point injections could be a simpler, safer option for people whose shoulder pain hasn't improved with other treatments.
Shoulder osteoarthritis is a common cause of chronic pain, especially in older adults, and it significantly affects quality of life. Research suggests that this medication might work well when injected into trigger points, but doctors want to know if it's truly as effective as the traditional approach of injecting directly into the joint.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either a trigger point injection or a joint injection in your shoulder. After your injection, you would visit the clinic for follow-up appointments at 2 weeks, 4 weeks, 8 weeks, 12 weeks, and 24 weeks to report your pain level and any side effects. The entire study lasts about 2 years, during which doctors will track how well the treatment is working and monitor your recovery.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China